Interaction Checker

Filgrastim interactions

Filgrastim (Neupogen, Zarxio, Nivestym) has 4 documented interactions across the FDA labels and fact sheets we index: 2 major, 2 moderate, 0 minor, and 0 where a label reports no significant interaction. Each entry below quotes the sentence behind it. This drug page is a starting point, not a verdict for your situation.

Interactions from the label

Major interactions (2)

  • EflapegrastimMajor

    Rolvedon is contraindicated in patients with a history of serious allergic reactions to eflapegrastim, pegfilgrastim, or filgrastim products. (Eflapegrastim label, Contraindications)

  • PegfilgrastimMajor

    NYPOZI is contraindicated in patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim products or pegfilgrastim products [see Warnings and Precautions (5.3) ]. (Filgrastim label, Contraindications)

Moderate interactions (2)

  • MotixafortideModerate

    Leukocytosis Administration of APHEXDA in conjunction with filgrastim increases circulating leukocytes as well as HSC populations. (Motixafortide label, Warnings and precautions)

  • PlerixaforModerate

    Hematologic Effects Leukocytosis Administration of Mozobil in conjunction with filgrastim increases circulating leukocytes as well as HSC populations. (Plerixafor label, Warnings and precautions)

Check Filgrastim against everything you take. Add your full list; every pair is checked at once.

Open in the checker

Not medical advice. Severity reflects the label's wording, not your circumstances. A "major" flag can be routine under supervision and a "minor" one can matter at high doses. Ask a pharmacist.